Karen Sue Cox Sells 2,000 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) insider Karen Sue Cox sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $124.50, for a total transaction of $249,000.00. Following the completion of the transaction, the insider owned 31,596 shares of the company’s stock, valued at approximately $3,933,702. The trade was a 5.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

CVSA opened at $128.78 on Thursday. The company has a market capitalization of $4.38 billion, a price-to-earnings ratio of 20.06, a P/E/G ratio of 1.07 and a beta of 0.63. Adtalem Global Education Inc. has a 1-year low of $86.97 and a 1-year high of $156.26. The stock has a 50 day moving average price of $113.02. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. The business had revenue of $487.03 million during the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.92 earnings per share. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Equities analysts anticipate that Adtalem Global Education Inc. will post 8.03 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Truist Financial upped their price target on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday. Barrington Research reaffirmed an “outperform” rating and set a $170.00 target price on shares of Adtalem Global Education in a research note on Friday, April 17th. Weiss Ratings assumed coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They set a “hold (c+)” rating for the company. Zacks Research cut shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Finally, Wall Street Zen cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.